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Abstract
Background: Birth size, and particularly birth length, is positively associated with breast cancer risk in adulthood.
The objective of this study was to examine whether birth size is associated with survival among breast cancer
patients.
Methods: Information on birth size (weight, length and ponderal index (kg/length (m3)) was collected from birth
archives for 331 breast cancer patients who were diagnosed at two university hospitals in Norway (Bergen and
Trondheim). The patients were followed from the time of diagnosis until death from breast cancer, death from
another cause, or to the end of follow-up, and birth size was related to survival, using Cox regression analysis.
Results: Breast cancer patients with birth length ≥ 52 cm had nearly twice the risk of dying (hazard ratio, 1.92,
95% confidence interval, 1.09-3.41) from breast cancer compared to women with birth length less than 48 cm,
after adjustment for place of birth and year of diagnosis.
Similar analyses related to birth weight and ponderal index showed no clear association with breast cancer
survival.
Conclusions: Poorer outcome of breast cancer patients with high birth length may reflect effects of factors that
stimulate longitudinal growth and simultaneously increase the risk of metastases and fatal outcome. It is possible
that the insulin-like growth factor (IGF) system is involved in the underlying mechanisms.
Background
During the last two decades, it has been shown that
birth size is positively associated with breast cancer risk
later in life. Thus, birth weight, birth length, and head
circumference have all shown positive associations with
breast cancer risk in studies that employed measure-
ments from birth records [1-3]. In a recent meta-analy-
sis, it was suggested that birth length may be a better
predictor than the other indicators of birth size [4],
thus, the insulin like growth factor system (IGF) may
somehow be implicated in the underlying mechanisms.
Among factors measured in adulthood, it has been
shown that body height is positively associated with
breast cancer risk. High body mass index (BMI) is also
associated with increased risk, but only among postme-
nopausal women. Among premenopausal women, BMI
appears to be inversely related to breast cancer risk
[5-7].
Less attention has been given to these factors as pre-
dictors of the prognosis among breast cancer patients.
Nonetheless, it has been shown that adult obesity is
adversely related to prognosis, both indicated as survival
and mortality from breast cancer, and this effect appears
to be equally strong for women with pre- and postme-
nopausal disease [8]. On the other hand, there is no
clear evidence that body height is associated with survi-
val from breast cancer [9]. With regard to birth size, we
are not aware of any study that has assessed the relation
with breast cancer survival.
In this study, we have therefore assessed whether birth
size is associated with survival of subsequent breast can-
cer, and in the analysis, we have adjusted for the influ-
ence of known prognostic factors such as lymph node
status and tumour diameter.
Methods
In order to have access to data on birth size, eligible
breast cancer patients had to be born in Trondheim or
Bergen, Norway. Therefore, we used data from the
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Norwegian Cancer Registry to identify women with
breast cancer who were residents in Trondheim or Ber-
gen at the time of diagnosis. The Central Person Regis-
try, which is administered by Statistics Norway,
provided the necessary information on place of resi-
dence at birth. That registry maintains continuously
updated records on each woman’s residential address
and the identity of the mother.
The information on birth weight and birth length for
patients born in Trondheim was collected from the
birth archive of EC Dahl’s Foundation that served as the
major birth clinic in Trondheim from 1910 to 1970.
Birth data from Bergen were derived from archives of
Bergen Birth Foundation and Midwife School, and later
from the Maternity Hospital in Bergen. The information
is stored at the Regional State Archives in Bergen. We
further used information from the Central Person Regis-
try of Norway to verify individual linkage between
women of the study and their birth records.
To be included, patients had to be singletons born at
term; birth length was restricted to range from 46 to 55
cm, and birth weight could range from 2000 to 5000
grams. In the analysis, we only included patients who
were treated with modified radical mastectomy. Among
373 potentially eligible patients, we could include 331
patients in the analysis for whom we had sufficient
information from birth. Perinatal information was
abstracted from birth records and included birth weight
(grams) and birth length (centimetres). As a measure of
body mass, independent of length, ponderal index was
calculated as birth weight divided by the cubed value of
birth length (kg/length(m)3). The correlation coefficient
between ponderal index and birth length was 0.00, and
between ponderal index and birth weight it was 0.66,
indicating that birth length and ponderal index may be
considered independent of each other.
Breast cancer specimens were examined at the Depart-
ment of Pathology, St Olav’s University Hospital in
Trondheim, or at the Department of Pathology, Hauke-
land University Hospital in Bergen. Information on
tumour diameter and lymph node status at diagnosis
was abstracted from the pathology reports.
In the statistical analysis, birth length, birth weight
and ponderal index were categorised into approximate
quintiles, and in subsequent analyses, the second, third
and fourth quintile were combined into one category
because of the range between the second and the fourth
quintile was small. Thus, each variable had three cate-
gories: the first category was the lowest quintile; the sec-
ond category was a combination of the second, third,
and fourth quintile, and the third category was the high-
est quintile. For birth weight, the first quintile included
weights below or equal to 3050 grams, and the fifth
quintile included birth weights above 3850 grams. The
corresponding threshold values for the lowest and high-
est quintile of birth length were 48 cm and 52 cm, and
for ponderal index, it was 25.0 kg/m3 and 29.1 kg/m3.
All patients were followed up by linkage to data from
the Causes of Death Registry at Statistics Norway.
Follow-up started at the date of diagnosis, and median
follow-up was 108 months. Women were censored at
the time of death, or at the end of follow-up. For
patients in Trondheim, follow-up ended on December
31, 1999, and for patients in Bergen, follow-up ended on
December 31, 2003. Death from breast cancer was the
primary endpoint, and no patient was lost to follow-up.
The Cox proportional hazards model was used to
estimate the relative risk of dying (hazard ratio) from
breast cancer related to the categories (see above) of
birth weight, birth length and ponderal index. The Cox
model is based on the assumption that death rates
between categories of patients are constant over time.
No serious deviations from the proportionality assump-
tion were found, based on plots of the log minus log
survival function (not shown). In a multivariable analy-
sis, we adjusted for place of birth and year of diagnosis,
and in additional analysis, we also took lymph node
status and tumour diameter at diagnosis into account.
All statistical analyses were done using SPSS, version
11.0 for Windows (SPSS Inc., Chicago, IL, USA).
The study was approved by the regional committee for
ethics in medical research.
Results
Patient characteristics are presented in Table 1, and
Table 2 shows the associations of birth size indicators
(length, weight and ponderal index) with breast cancer
specific survival, after adjustment for place of birth and
year of diagnosis. The results indicate that women who
were longer than 52 cm at birth had 92% higher risk
(hazard ratio 1.92, 95% confidence interval, 1.09-3.41) of
dying from breast cancer compared to patients who
were 48 cm or shorter. A test for linear trend across
birth length provided a p-value of 3%. We found no
clear associations with survival related to birth weight or
ponderal index.
Since ponderal index and birth length play indepen-
dent roles, both variables were included in the subse-
quent multivariable analyses (Table 3). In addition, we
included place of birth and year of diagnosis in the ana-
lysis (Analysis A, Table 3). The results were quite simi-
lar to those shown in Table 2. In subsequent analyses,
we also included lymph node status (positive vs. nega-
tive) (Analysis B, Table 3), and tumour diameter (Analy-
sis C, Table 3) as co-variates. Information on lymph
node status was missing in 39 patients, and tumour dia-
meter was missing in 86 patients; and in analysis B in
Table 3, we therefore included 293 patients, and in
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analysis C, 246 patients were included. The results show
that survival among patients within the highest quintile
of birth length remained consistently poorer than for
patients in lower categories of birth length, also after
taking lymph node status and tumour diameter into
account (Table 3). Detailed correlation analyses showed
no correlations between birth length and tumour dia-
meter (-0.056), and between birth length and lymph
node status (-0.017).
Discussion and Conclusions
We have studied whether birth size is associated with
the prognosis of breast cancer patients, and found that
women with high birth length had poorer outcome than
women with shorter length at birth. Specifically, women
who were 52 cm or longer at birth had nearly twice the
risk of dying from breast cancer compared to women
who were shorter than 48 cm at birth. This association
was not reduced after taking ponderal index, lymph
node status, tumour diameter and place of birth into
account. We found no association with survival related
to birth weight or ponderal index.
In prognostic studies, predictors are usually assessed
at the time of diagnosis, and patients are subsequently
followed up in relation to outcome, which is typically
time to death (survival) from the specified disease under
study. In this study, however, measurements of birth
size were made decades before the diagnosis (on average
50 years earlier). In the literature, there is no evidence
that indicators of birth size have any influence on the
prognosis of breast cancer once the diagnosis is estab-
lished, and previously, no study has assessed survival of
breast cancer related to birth size. However, given the
magnitude of the association that we observed for birth
length, sources of bias that may explain the finding
should be carefully considered.
It is conceivable that better prognosis in one subgroup
of patients could be due to better treatment quality.
Birth length is positively correlated with adult height,
and hence with socioeconomic status [10,11]. If quality
of care and treatment followed a socio-demographic
gradient, women with high birth length would be
expected to receive better treatment. In that scenario
the higher risk of dying from breast cancer related to
Table 1 Number of breast cancer patients and patient characteristics in Trondheim and in Bergen
Bergen Trondheim
No Mean (SD) Range No Mean (SD) Range
Age (years) 165 52.1(11.4) 27-83 166 49.0 (10.3) 30-73
Birth length (cm) 165 50.3 (1.62) 46-54 166 50.4 (1.91) 46-54
Birth weight (g) 164 3486 (466) 2310-4900 165 3436 (493) 2320-4800
Ponderal index (kg/m3) 164 27.3(2.69) 17.1-34.3 165 26.8 (2.2) 18.6-32.2
Positive lymph node status 138 39% 154 47%
Tumour diam. (cm) 110 2.3 (1.3) 0.5-8.0 133 3.2 (1.9) 0-8.0
Number of breast cancer deaths 29 58
Number of deaths from other causes 5 14
Numbers lost to follow-up 0 0
Follow-up time (months) 165 142 4-487 166 125 5-354
Table 2 Hazard ratios (with 95% confidence intervals) of
dying from breast cancer according to birth length, birth
weight and ponderal index, with adjustment for place of
birth and year of diagnosis
Birth length Birth weight Ponderal index
N = 331 N = 329 N = 329
1st quintile 1.0 (reference) 1.0 (reference) 1.0 (reference)
2-4th quintiles 1.08 (0.61,1.88) 1.08 (0.62,1.88) 1.01 (0.59,1.74)
5th quintile 1.83 (1.03,3.25) 1.16 (0.59,2.29) 0.81 (0.39,1.67)
p-value linear trend p = 0.03 p = 0.59 p = 0.11
Table 3 Hazard ratios (with 95% confidence intervals) of
dying from breast cancer according to birth length and
ponderal index
A B C
N = 329 N = 293 N = 246
Birth length
1st quintile (< 48 cm) 1.0 (reference) 1.0 (reference) 1.0 (reference)
2-4th quintiles
(48-52 cm)
1.07
(0.61, 1.86)
1.15
(0.64, 2.08)
1.21
(0.61, 2.39)
5th quintile (> 52 cm) 1.84
(1.03, 3.28)
1.88
(1.03, 3.45)
2.17
(1.06, 4.45)
Ponderal index
1st quintile 1.0 (reference) 1.0 (reference) 1.0 (reference)
2-4th quintiles 0.93
(0.54, 1.61)
0.82
(0.47, 1.43)
0.95
(0.50, 1.83)
5th quintile 0.80
(0.39, 1.65)
0.65
(0. 30, 1.38)
0.91
(0.38, 2.20)
Estimates adjusted for place of birth and year of diagnosis (A), with additional
adjustment for lymph node status (B) and tumour diameter (C).
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high birth length that we found in our study is likely to
be underestimated. In Norway, however, all cancer treat-
ment is free of cost, and this is likely to reduce the
potential for bias due to differences in access to and
quality of treatment.
Another possible source of bias could be that the
association of birth length with adult socioeconomic sta-
tus, including higher education, could lead to earlier
diagnosis in women with high birth length. This possibi-
lity could result in lead time bias, where survival from
diagnosis to death would be longer among patients with
high birth length compared to women with shorter
birth length, who may be diagnosed at a later stage.
Also under this scenario, however, the poorer outcome
in patients with high birth length is likely to be
underestimated.
The secular increase in birth length that took place in
the 20th century may also be a concern. In an attempt to
take effects of calendar time (period) into account, we
adjusted for year of birth, but this did not influence the
estimates of effect. However, this adjustment may not be
sufficient to account for secular changes in birth length.
It is also possible that important but unmeasured con-
founding factors could explain the poorer outcome of
patients with high birth length. For such a factor to be
of practical interest, however, it would have to be
strong, and substantially influence breast cancer survival.
Few known prognostic factors meet these criteria, and
they are typically variables that describe the stage of the
disease at the time of diagnosis, and therefore, these are
not factors that could influence birth lenth. In the analy-
sis, we adjusted for lymph node status and tumour dia-
meter, but the adjustment did not substantially
influence the results. However, body weight is a factor
that does influence the prognosis of breast cancer
patients [9]. Birth length is both associated with adult
height and weight [11,12], but it is not clear if adult
weight should be considered as a potentially confound-
ing factor in relation to breast cancer survival. Maybe it
is more appropriate to consider the effect of adult body
size to be a possible mediator on the causal pathway
from birth length to the outcome of breast cancer.
Conclusions
It is difficult to see any practical implication of the find-
ing that high birth length is associated with a poorer
prognosis of breast cancer. Nonetheless, by establishing
a link between conditions that operate in utero and the
development and prognosis of later breast cancer, these
results may be helpful in guiding investigators towards
prognostic mechanisms. The relatively strong association
of birth length, indicating longitudinal growth, may sug-
gest that the insulin like growth factor (IGF) system is
involved in the underlying mechanisms.
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